MODERATE RISK OF HEPATITIS B VIRUS REACTIVATION IN HBsAg-/HBcAb+ CARRIERS RECEIVING RITUXIMAB FOR RHEUMATOID ARTHRITIS

被引：0
|
作者：
Kuo, Meng Hsuan [1 ]
Tseng, Chi-Wei [2 ]
Lee, Chi-Hui [1 ]
机构：
[1] Dalin Tzu Chi Hosp, Pharm, Chiayi, Taiwan
[2] Tzuchi Univ, Sch Med, Hualien, Taiwan
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1028
引用
收藏
页码：624A / 624A
页数：1
相关论文
共 50 条
  • [41] Hepatitis B Virus Reactivation Following Salazosulfapyridine Monotherapy in a Patient with Rheumatoid Arthritis
    Akashi, Kengo
    Saegusa, Jun
    Nakamachi, Yuji
    Nakazawa, Takashi
    Kumagai, Shunichi
    Morinobu, Akio
    INTERNAL MEDICINE, 2016, 55 (10) : 1371 - 1373
  • [42] Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas
    Lan, Ting-Yuan
    Lin, Yen-Chun
    Tseng, Tai-Chung
    Yang, Hung-Chih
    Kao, Jui-Hung
    Cheng, Chiao-Feng
    Lee, Tai-Ju
    Huang, Shang-Chin
    Lu, Cheng-Hsun
    Li, Ko-Jen
    Hsieh, Song -Chou
    GUT AND LIVER, 2023, 17 (02) : 288 - 298
  • [43] Hepatitis B Virus Reactivation in a Patient With Resolved Hepatitis B Virus Infection Receiving Maintenance Rituximab for Malignant B-Cell Lymphoma
    Koo, Yu Xuan
    Tan, Daniel S. W.
    Tan, Iain B.
    Tao, Miriam
    Lim, Soon Thye
    ANNALS OF INTERNAL MEDICINE, 2009, 150 (09) : 655 - 656
  • [44] Risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: a meta-analysis
    Zilin Tang
    Xiaodong Li
    Shunquan Wu
    Yan Liu
    Yan Qiao
    Dongping Xu
    Jin Li
    Hepatology International, 2017, 11 : 429 - 433
  • [45] Risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients with undetectable serum HBV DNA after treatment with rituximab for lymphoma: a meta-analysis
    Tang, Zilin
    Li, Xiaodong
    Wu, Shunquan
    Liu, Yan
    Qiao, Yan
    Xu, Dongping
    Li, Jin
    HEPATOLOGY INTERNATIONAL, 2017, 11 (05) : 429 - 433
  • [46] Incidence Of Hepatitis B Virus Reactivation In Patients With Rheumatoid Arthritis During Treatment With Biologics
    Nakamura, Jun
    Nagashima, Takao
    Nagatani, Katsuya
    Yoshio, Taku
    Iwamoto, Masahiro
    Minota, Seiji
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S577 - S577
  • [47] Hepatitis B virus reactivation in patients with rheumatoid arthritis: A single-center study
    Matsuzaki, Toshihisa
    Eguchi, Katsumi
    Nagao, Natsumi
    Tsuji, Sousuke
    Aramaki, Toshiyuki
    Terada, Kaoru
    Iwatsu, Shinichi
    Tokimura, Ikuko
    Kamo, Yasuhiro
    Oda, Hidetoshi
    Kinoshita, Noboru
    Miyaaki, Hisamitsu
    Taura, Naota
    Ichikawa, Tatsuki
    Kawakami, Atsushi
    Nakao, Kazuhiko
    Ueki, Yukitaka
    MODERN RHEUMATOLOGY, 2018, 28 (05) : 808 - 813
  • [48] Hepatitis B virus reactivation in patients with rheumatoid arthritis: Analysis of the National Database of Japan
    Fujita, M.
    Sugiyama, M.
    Sato, Y.
    Nagashima, K.
    Takahashi, S.
    Mizokami, M.
    Hata, A.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (11) : 1312 - 1320
  • [49] Hepatitis B virus reactivation in rituximab-treated patients: incidence and risk factors
    Gutierrez Garcia, Maria Luisa
    Alonso Lopez, Sonia
    Martin Rios, Maria Dolores
    Sanmartin Fenollera, Patricia
    Agudo Fernandez, Sandra
    Fernandez Rodriguez, Conrado Manuel
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2015, 38 (01): : 1 - 6
  • [50] Prevention of Hepatitis B Virus Reactivation in HBsAg-Positive Renal Transplant Recipients with Rituximab Treatment.
    Choi, Ji Yoon
    Jung, Joo Hee
    Kwon, Hyunwook
    Shin, Sung
    Kim, Young Hoon
    Han, Duck Jong
    TRANSPLANTATION, 2018, 102 : S521 - S521
12345